Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial
Lulu Bravo(University of the Philippines Manila), Igor Smolenov, Htay Htay Han, Ping Li, Romana Hosain, Frank W. Rockhold(Clinical Research Institute), Sue Ann Costa Clemens(University of Oxford), Camilo C. Roa, Charissa Borja-Tabora(Asian Hospital and Medical Center), Antoinette Quinsaat(National Centre for Infectious Diseases), Pío López(Universidad del Valle), Eduardo López‐Medina(Universidad del Valle), L Brochado, Eder Hernández(Universidad del Norte), Humberto Reynales, Tatiana Medina, Hector Velásquez, Leonardo Bautista Toloza, Edith Johana Rodriguez, Dora I. Molina(University of Caldas), Camilo Alejandro Corchuelo Rodríguez(Universidad del Norte), Eduardo Sprinz(Universidade Federal do Rio Grande do Sul), José Cerbino-Neto(D’Or Institute for Research and Education), Kléber Giovanni Luz(Universidade Federal do Rio Grande do Norte), Alexandre Vargas Schwarzbold(Universidade Federal de Santa Maria), Maria Sanali Moura de Oliveira Paiva, Josefina Carlos(University of the East Ramon Magsaysay Memorial Medical Center), May Emmeline B. Montellano(Far Eastern University), Mari Rose A de Los Reyes, Charles Yu, Edison Alberto(Tropical Disease Foundation), Mario Panaligan(St. Luke's Medical Center), Milagros Salvani-Bautista(University of the East Ramon Magsaysay Memorial Medical Center), Erik Buntinx, Maya Hites(Erasmus Hospital), Jean‐Benoît Martinot(UCLouvain), Qasim Bhorat(Soweto CTC), Aysha Badat, Carmen Baccarini, Branda Hu, Jaco Jurgens, Jan Engelbrecht(Right to Care), Donna M. Ambrosino, Peter Richmond(The Kids Research Institute Australia), George R. Siber, Joshua G. Liang(Clover Biopharmaceuticals (China)), Ralf Clemens(GlaxoSmithKline (Brazil))
Cited by 113Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis